Epizyme (EPZM)

Executive Summary

Epizyme, Inc., a late-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases. More Details


Snowflake Analysis

Excellent balance sheet with limited growth.

Search for a company to compare.